Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

Startup Vitasense today said it secured significant funding to advance its non-invasive wearable glucose monitoring ...

The FDA today issued a notice warning of a potential high-risk issue with certain Baxter Spectrum infusion pump systems.

Senseonics (NYSE:SENS) shares ticked up after hours today on fourth-quarter results that came in ahead of the consensus ...

The Eversense 365 long-term implantable CGM. [Image courtesy of Senseonics/Ascensia] Senseonics (NYSE:SENS) announced today that it integrated SweetSpot software with its Eversense 365 continuous ...